If clinically appropriate, MIC B12 injection therapy may be prescribed through ARSYNL Rx medical providers and delivered according to the patients plan
Major appetite suppressant
Self-reported adverse effects from patients who used BPC-157 before the restrictions include injection site pain, joint discomfort, anxiety, heart palpitations, insomnia, fatigue, and mood changes
(Dependent on patient's needs) Dose: 250 g (also known as micrograms(mcg))in cats and 250 2000 g (also known as micrograms (mcg))in dogs, depending on the size of the patient: For parenteral cobalamin supplementation: Protocol: weekly injections for 6 weeks, then one dose a month later, and retesting one month after the last dose( dependent on patient's needs) For either oral or parenteral supplementation, if the underlying disease process has resolved and cobalamin body stores have been replenished, serum cobalamin concentration should be supranormal at the time of reevaluation
The active content has been identified as the N-terminal acetylated 17-23 fragment of Thymosin Beta-4 (Ac-LKKTETQ)
Some peptides, particularly BPC-157 and Larazotide, have shown promise for the inflammation and barrier-function pathways that often drive IBS symptoms
